The Current Price For Amedisys Inc. (NASDAQ: AMED): And Is It Worth Investing In?

view original post

During the last session, Amedisys Inc. (NASDAQ:AMED)’s traded shares were 0.55 million, with the beta value of the company hitting 0.52. At the end of the trading day, the stock’s price was $155.35, reflecting an intraday loss of -3.83% or -$6.18. The 52-week high for the AMED share is $325.12, that puts it down -109.28 from that peak though still a striking -3.7% loss since the share price plummeted to a 52-week low of $161.10. The company’s market capitalization is $5.01B, and the average intraday trading volume over the past 10 days was 0.34 million shares, and the average trade volume was 332.60K shares over the past three months.

Amedisys Inc. (AMED) received a consensus recommendation of an Overweight from analysts. That translates to a mean rating of 2.00. AMED has a Sell rating from 1 analyst(s) out of 15 analysts who have looked at this stock. 4 analyst(s) recommend to Hold the stock while 1 suggest Overweight, and 9 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be $1.36.


3 Tiny Stocks Primed to Explode The world’s greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We’ve set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Amedisys Inc. (AMED) registered a -3.83% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -3.83% in intraday trading to $155.35 this Friday, 09/24/21, hitting a weekly high. The stock’s 5-day price performance is -9.22%, and it has moved by -13.20% in 30 days. Based on these gigs, the overall price performance for the year is -30.83%. The short interest in Amedisys Inc. (NASDAQ:AMED) is 0.55 million shares and it means that shorts have 2.79 day(s) to cover.

The consensus price target of analysts on Wall Street is $234.43, which implies an increase of 33.73% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $150.00 and $265.00 respectively. As a result, AMED is trading at a discount of -70.58% off the target high and 3.44% off the low.

Amedisys Inc. (AMED) estimates and forecasts

Statistics show that Amedisys Inc. has outperformed its competitors in share price, compared to the industry in which it operates. Amedisys Inc. (AMED) shares have gone down -42.71% during the last six months, with a year-to-date growth rate more than the industry average at -0.49% against -2.00. Yet analysts are ramping up their growth forecast for the fiscal year 2021. Revenue is predicted to shrink -39.30% this quarter and then drop -2.00% in the quarter after that. In the rating firms’ projections, revenue will increase 8.80% compared to the previous financial year.

Revenue for the current quarter is expected to be $566.85 million as predicted by 11 analyst(s). Meanwhile, a consensus of 11 analyst(s) estimates revenue growth to $585.2 million by the end of Dec 2021.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 128.50%. While earnings are projected to return 43.60% in 2021, the next five years will return 8.29% per annum.

AMED Dividends

Amedisys Inc. is due to release its next quarterly earnings between October 26 and November 01. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Amedisys Inc. (NASDAQ:AMED)’s Major holders

Amedisys Inc. insiders own 1.53% of total outstanding shares while institutional holders control 89.15%, with the float percentage being 90.53%. Blackrock Inc. is the largest shareholder of the company, while 537 institutions own stock in it. As of Mar 30, 2021, the company held over 4.1 million shares (or 12.59% of all shares), a total value of $1.09 billion in shares.

The next largest institutional holding, with 3.12 million shares, is of Vanguard Group, Inc. (The)’s that is approximately 9.58% of outstanding shares. At the market price on Mar 30, 2021, these shares were valued at $826.57 million.

>> 7 Top Picks for the Post-Pandemic Economy <<

Also, the Mutual Funds coming in first place with the largest holdings of Amedisys Inc. (AMED) shares are Vanguard Total Stock Market Index Fund and iShares Core S&P Midcap ETF. Data provided on Mar 30, 2021 indicates that Vanguard Total Stock Market Index Fund owns about 0.93 million shares. This amounts to just over 2.84 percent of the company’s overall shares, with a $245.28 million market value. The same data shows that the other fund manager holds slightly less at 0.9 million, or about 2.76% of the stock, which is worth about $242.38 million.